ICU Medical, Inc. (ICUI)
Total Valuation
ICU Medical has a market cap or net worth of $2.83 billion. The enterprise value is $4.29 billion.
Market Cap | 2.83B |
Enterprise Value | 4.29B |
Important Dates
The next estimated earnings date is Monday, November 6, 2023, after market close.
Earnings Date | Nov 6, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.14 million shares outstanding. The number of shares has increased by 0.74% in one year.
Shares Outstanding | 24.14M |
Shares Change (YoY) | +0.74% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 16.19% |
Owned by Institutions (%) | 95.09% |
Float | 20.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 19.70 |
PS Ratio | 1.24 |
Forward PS | 1,226.04 |
PB Ratio | 1.34 |
P/FCF Ratio | n/a |
PEG Ratio | 1.35 |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.87 |
EV / EBITDA | 16.70 |
EV / EBIT | 1,048.58 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.78.
Current Ratio | 2.57 |
Quick Ratio | 0.74 |
Debt / Equity | 0.78 |
Debt / EBITDA | 6.39 |
Debt / FCF | n/a |
Interest Coverage | 0.05 |
Financial Efficiency
Return on equity (ROE) is -2.30%.
Return on Equity (ROE) | -2.30% |
Return on Assets (ROA) | -1.10% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $158,195 |
Profits Per Employee | -$3,344 |
Employee Count | 14,500 |
Asset Turnover | 0.51 |
Inventory Turnover | 2.28 |
Taxes
Income Tax | -30.52M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.71% in the last 52 weeks. The beta is 0.65, so ICU Medical's price volatility has been lower than the market average.
Beta (1Y) | 0.65 |
52-Week Price Change | -21.71% |
50-Day Moving Average | 144.46 |
200-Day Moving Average | 167.76 |
Relative Strength Index (RSI) | 19.22 |
Average Volume (30 Days) | 203,863 |
Short Selling Information
The latest short interest is 1.10 million, so 4.58% of the outstanding shares have been sold short.
Short Interest | 1.10M |
Short Previous Month | 1.16M |
Short % of Shares Out | 4.58% |
Short % of Float | 5.46% |
Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.29 billion and -$48.49 million in losses. Loss per share was -$2.01.
Revenue | 2.29B |
Gross Profit | 745.71M |
Operating Income | 9.89M |
Pretax Income | -79.01M |
Net Income | -48.49M |
EBITDA | 256.66M |
EBIT | 4.09M |
Loss Per Share | -$2.01 |
Balance Sheet
The company has $197.70 million in cash and $1.64 billion in debt, giving a net cash position of -$1.44 billion or -$59.80 per share.
Cash & Cash Equivalents | 197.70M |
Total Debt | 1.64B |
Net Cash | -1.44B |
Net Cash Per Share | -$59.80 |
Equity / Book Value | 2.11B |
Book Value Per Share | 87.62 |
Working Capital | 760.86M |
Cash Flow
In the last 12 months, operating cash flow was $40.37 million and capital expenditures -$82.47 million, giving a free cash flow of -$42.10 million.
Operating Cash Flow | 40.37M |
Capital Expenditures | -82.47M |
Free Cash Flow | -42.10M |
FCF Per Share | -$1.75 |
Margins
Gross margin is 32.51%, with operating and profit margins of 0.43% and -2.11%.
Gross Margin | 32.51% |
Operating Margin | 0.43% |
Pretax Margin | -3.44% |
Profit Margin | -2.11% |
EBITDA Margin | 11.19% |
EBIT Margin | 0.18% |
FCF Margin | -1.84% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -1.71% |
FCF Yield | -1.48% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.74% |
Shareholder Yield | -0.74% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 3.95% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 3:2.
Last Split Date | Mar 18, 2002 |
Split Type | Forward |
Split Ratio | 3:2 |